Klicken Sie auf den unteren Button, um den Inhalt von open.spotify.com zu laden.
Interview with Maria Costa and Shahrul Mt-Isa Benefit-risk assessments are made by various stakeholders including sponsors, regulators, payers, physicians, and patients throughout the life-cycle of a treatment. The understanding of data plays a vital role in weighting positive and negative effects of medications. In this episode, we give you an
Interview with Kate Taylor – chair of the PSI conference in 2019 Hopefully, you’re attending statistical conferences to learn more about the latest developments in the field. But of course, there’s much more to conferences than just the sessions. In this episode, I’m chatting with Kate Taylor – the chair
Interview with Stephen Ruberg There’s a long tradition of statisticians working on clinical studies as well as other related data, e.g. pre-clinical data and observational data. In the advent of big data and data sciences, there’s a considerable pull from the business side of pharma to employ statistical approaches as
Do you know that TransCelerate does for statisticians? Do you write study protocols, analysis plans and programming specifications as individual documents noting, that there’s lots of redundancy? Do you wonder, if there’s a more efficient was in-line with what regulators want? Never miss an episode! Join thousends of your peers
Never miss an episode!
Join thousends of your peers and subscribe to get our latest updates by email!
Get the
Success! Now check your email to confirm your subscription.